Elevance Health Q2 Adj. EPS $7.45 Beats $6.21 Estimate, Sales $49.826B Beat $48.693B Estimate

Elevance Health (NYSE:ELV) reported quarterly earnings of $7.45 per share which beat the analyst consensus estimate of $6.21 by 19.97 percent. This is a 15.72 percent decrease over earnings of $8.84 per share from the same period last year. The company reported quarterly sales of $49.826 billion which beat the analyst consensus estimate of $48.693 billion by 2.33 percent. This is a 0.82 percent increase over sales of $49.421 billion the same period last year.